Publication | Open Access

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

Lymphoid NeoplasiaCell TherapyTransplantationMarrow TransplantationOncologyConsolidation TherapyCell TransplantationCancer TreatmentImmunotherapyMedicineRadiation OncologyAutologous Stem-cell TransplantationBrentuximab Vedotin